One critical aspect of oncology drugmakers' business remains firmly rooted in the past. That's customer experience.
A new bill exempting CME reporting gains physician support; NYT op-ed calls Opdivo DTC ad "misleading;" Valeant to sell non-core assets worth $8 billion
We need to consider that not every expenditure is beneficial to patients: perhaps that Super Bowl commercial or that sales meeting in Maui may not be in their best interest.
The main accreditation body for CME activities traded barbs with an academic critic over courses designed to enlighten doctors about hypoactive sexual desire disorder.
There is an immediate need for greater education regarding halal and vaccines for Muslim consumers worldwide.
Physicians criticize pricing of Orkambi, Vertex's new cystic-fibrosis drug; the EU approves Amgen's PCSK9 inhibitor Repatha; PhRMA boosts lobbying spending in the second quarter
New rules will require manufacturers to report some indirect payments made to physicians for CME activities.
Vesey Street Capital Partners acquired Atlanta-based CME provider Imedex.
Pharma's efforts to evolve restrictions about off-label marketing move forward.
The legislation would allow drugmakers to share information about their products beyond what is included on the FDA-approved label.
Last year's increase in CME support from manufacturers came after six straight years of declining budgets.
Purdue withdraws plans to participate in FDA meeting on painkillers; Allscripts takes 10% stake in NantHealth in advance of IPO; union advocates to end pharma support for CME
With an eye on the bottom line, hospitals and their marketing firms traditionally haven't spent much time on school campuses.
Medscape marked its 20th anniversary with a reunion this week that attracted staffers from the portal's earliest days.
The legislation would allow drugmakers to share economic information with payers beyond what is included on the FDA-approved label.
The draft would allow drugmakers to share off-label economic data with payers, a practice that until now has been considered taboo, and require the FDA to assess patient experience data in regulatory decisions, in addition to boosting funding for the NIH.
Shire's ADHD treatment Vyvanse won a label expansion into treating moderate-to-severe binge-eating disorder (BED) Friday. One analyst says that disease awareness and detailing efforts are crucial to the drug's commercial plans in the category.
The artwork is meant to inspire debate and donations for vaccinations.
"We are living in an era of great medical technological innovations. However, this is shifting healthcare back home and expecting patients to understand excessive medical information and follow complex instructions."
CMS redefined the Sunshine CME exemption, still allowing most payments to go unreported.
The new initiative will look to recruit a teenager with epilepsy to appear in the next iteration of its educational comic book series.
Using the same methods they use to stimulate demand for a brand, agencies can educate communities and ultimately transform how countries approach healthcare, urges H.E. Toyin Saraki.
Recent research suggests nurse practitioners and physicians assistants have a growing appetite for digital patient resources from industry.
After a wave of feedback, the accreditor has deferred a ban on use of corporate logos in disclosures of commercial support.
The Cleveland Clinic finds that 75% of Americans don't worry about dying of heart disease, even though it's the country's leading killer.
J&J's campaign picks up where the FDA left off when it alerted physicians to concerns about prescribing acetaminophen-containing drugs but deferred action relative to OTC products.
The accreditor wants comments on its new accreditation plan, but a new commendation proposal is yet to come.
Pew Charitable Trust's proposed conflict of interest guidelines could mean even less face time for sales reps and less industry money for CME programs.
The publisher says the latest release enriches the CE experience through direct links to Nursing Advisor content.
The agency made good on a pledge to expand Bad Ad with a web-based CME course and case studies representing common problems.
Attendance by physicians crept up in 2012, said the trade group HCEA, but overall turnout was flat, likely because exhibitors brought less personnel along to meetings.
Some providers of CME are getting better at complying with accreditation criteria, data show, yet many are still struggling to meet a stricter set of requirements.
The company narrowed its second quarter loss, but said its national TV campaign is driving an uptick in consumer interest.
Pharma's med-ed cut was its fifth in a row. But other income surged, filling the void as the funding picture for CME continued to even out.
With a clear buffet exemption in-hand, the agency's position with respect to CME meals seems pretty clear. Industry is pushing for more clarity around the treatment of accrediting bodies.
The estimated cost savings for only 10% of participants changing their practice is somewhere in the million-dollar range, according to a study.
A CME activity was associated with increased testing that could head off neuropathy in patients with type 2 diabetes.
Boehringer Ingelheim and Eli Lilly rolled out a pre-launch SGLT campaign that breaks ranks with branding for J&J's SGLT2 inhibitor Invokana.
Medical science liaisons will educate nuclear-medicine clinicians as part of the launch of a new Navidea diagnostic agent for use in breast and skin cancer.
Welcome to the ambivalent world of healthcare, where confusion reigns as shifts in science and guidelines seemingly raise more questions than they answer.
New transparency rules set to lay bare financial ties between physicians and pharma will be a mixed bag for medical education, providers say.
Lack of access to patient-education materials in appropriate languages remains providers' biggest obstacle to serving culturally diverse patient populations, researchers found.
CMS issued its long-delayed final rule for collecting data on industry payments to physicians, ordering data collection to begin in August and asserting that the federal law preempts state laws.
MDLinx owner M3 Group is partnering with Argentine online CME firm Medcenter on a content-sharing deal that will expand its in-language reach to Spain, Portugal and Latin America.
The American Heart Association is trying to get us thinking about using social networks—in both the old-school, interpersonal connections sense as well as the newer electronic one—to tackle childhood obesity.
A new campaign from J&J's DePuy Orthopedics, aimed at raising awareness of joint replacement, features Baby Boomers' letters to their younger selves.
The med-ed company is buying Amazing Charts, a tie-up the firms say will enable them to deliver customized education to physicians and then assess the patient-level impact.
Sanofi has recruited actress Elizabeth Perkins, who has type 1 diabetes, to serve as the face of its Diabetes Co-Stars awareness campaign.
The American Medical Association has wooed New England Journal of Medicine publisher Tom Easley to Chicago, where he will preside over the society's publications, soon to be rolled up into the JAMA brand.
Only 35% of physicians are aware of the FDA's class-wide safety plan for certain opioids, a survey showed, suggesting an awareness challenge as the plan gets under way.
Physicians are reconsidering their participation in industry-sponsored CME, fearful that their inclusion in Sunshine Act databases as having received payments from companies will tarnish their reputations and fuel perceptions of conflicts of interest, a survey has found.
Three drugmakers teamed up with Catalina Health to design prescription-information sheets patients will actually read and understand.
Five patients will document their challenges and triumphs online in this project developed by the National MS Society and Sanofi's Genzyme unit.
Many health education materials delivered by HCPs end up being viewed as print-outs, one study suggests.
A new video-based educational series will aim to tailor content to both patients and physicians, the firms behind the effort say.
The drug industry dialed back its continuing medical education (CME) grant-giving in 2011, continuing a negative trend of the last few years.
The Alliance for Continuing Education in the Health Professions (ACEHP) named a new executive director, and mobile health app firm Preventice hired a director of global business development.
The FDA's opioid REMS safety plan is challenged on two fronts: getting CME providers to offer courses and getting doctors to attend them. Can the agency's scheme educate enough physicians to curb an epidemic?
A series of emails published by the New York Times Monday is bringing renewed attention to the Cox-2 inhibitor category.
Former Steelers coach Bill Cowher is fronting a Bristol-Myers Squibb-backed Melanoma Exposed awareness campaign.
What-to-expect videos were associated with lower rates of pain and increased surgery satisfaction, according to a study that focused on cancer patients.
The National Bone Health Alliance and inVentiv shop GSW Worldwide are launching 2Million2Many, a national education campaign designed to raise awareness of the connection between osteoporosis and broken bones.
Could an online quiz be the future of continuing medical education? In a twist on the "edu-gaming" phenomenon, Cleveland Clinic and physician site MDLinx aim to answer that question with The Smartest Doc, a daily one-minute quiz that aims to keep doctors up to date on the medical literature by appealing to their competitive spirit.
Progress in keeping commercial bias from industry-based certified CME is at hand, say those who produce and fund it.
Damon Marquis wants to make one thing clear: CME is not the only important form of medical education.
Those who produce and fund certified medical education acknowledge that conflict of interest is one issue that seems to constantly crop up. But while conflict is inevitable, bias doesn't have to be, they insist in a new video.
Genentech is sponsoring a flu education campaign featuring hereditary etiquette expert Anna Post offering advice to the flu-stricken on keeping the bug to themselves.
Healthline Networks has secured a deal with Drugs.com giving it exclusive rights to sell consumer ads on the site, which boasts 8.8 million unique visitors per month.
Janssen Biotech wrapped up its IBD Icons campaign on Sunday with an American Idol star crowning the winners of the user-generated content contest at a benefit for the Crohn's & Colitis Foundation of America (CCFA).
Pfizer is changing the way it funds medical education to make smarter use of a shrinking pool of funds and to enhance the impact of activities it supports.
Pri-Med founder John Mooney and his former management team have returned to the firm, which is under new ownership following M|C Holding's sale of Pri-Med's US assets to Canadian event and media producer Diversified Business Communications.
Sanofi Pasteur launched an education campaign aimed at blunting increasing skepticism of childhood vaccinations.
The launch of new cancer pill Jakafi will require extensive education, said Incyte Pharmaceuticals, owing partly to low awareness levels among doctors.
Krystexxa maker Savient has recruited Jim Belushi for an awareness-raising campaign dubbed "Check Out Your Gout."
A little over half of US girls ages 13 to 17 have not gotten even one dose of the HPV vaccine, and among the main reasons are poor awareness and the failure of doctors to recommend vaccination, a study shows.
McCann Healthcare Worldwide launched McCann Global Health, a new consumer comms shop that will make a play for the public health education space, doing large scale disease education in the US and globally.
Underscoring the importance of social media in public health, patients say friends and family are as responsible for their health as are medical professionals, according to Edelman's 2011 Health Barometer study.
It probably won't have the same ability to tap industry for support, but a new med-ed center at Stanford has some other interesting parallels with the school's CME program.
Defensive tackle-turned-sports radio talker Mike Golic has signed on to Merck and the American College of Endocrinology's Blood Sugar Basics program, which emphasizes the import of blood sugar control for people with type 2 diabetes.
Doctors are still getting their CME, but mostly the non-commercially supported kind.
State-accredited CME providers continue to decrease, with 68 dropping out as of last year, but so far the trend has not posed a threat to physician education, one official says.
Novo Nordisk is getting in on the boom in electronic publishing with a series of e-books available through its Cornerstones4Care patient support program.
The ACCME awarded provisional two-year accreditation to Lighthouse Learning, the educational content provider which develops and sells CME curricula without accepting commercial funding.
WebMD is expanding its wellness and prevention offering with several children's fitness sites aimed at besting childhood obesity.
Corporate logos may still appear in CME commercial support disclosures, ACCME said, after a majority of respondents expressed disapproval of its proposal to ban them.
The drug industry's backing of certified CME fell for a third straight year, as registration fees and other income surged, just-released data from ACCME show.
In a sign of industry's ongoing desire to broaden its CME funding outlook, a couple of recently supported educational programs by Pfizer aim to foster practice-based improvement as they seek to advance the science of CME.
Kim Kardashian revealed she has psoriasis on Sunday, when her diagnosis with the disease featured in an episode of her show, "Keeping Up With The Kardashians."
Everyday Health is planting its flag in network television with an ABC show that is being produced by "The Biggest Loser" creator Mark Koops.
A new survey shows certified CME bested dinner meetings, mailings and even sales rep visits in one promotional measure.
Uloric-maker Takeda and Men's Health Network recruited a pair of racing world rivals to hype a gout awareness campaign, dubbed "Gout Pit Stop."
A new report passed by AMA delegates draws ethical boundaries around the use of industry funding for medical education, stopping well short of the all-out ban seen in some previous versions.
Specialty drug company ViroPharma teamed with several medical societies on the launch of a program designed to unite specialists treating patients with the orphan condition hereditary angioedema (HAE).
Merck is launching a chronic hepatitis C awareness campaign featuring rocker and hepatitis C sufferer Gregg Allman, whose Allman Brothers Band will headline a benefit concert on World Hepatitis Day on July 27, in New York.
Eli Lilly & Co. refreshed its Lilly for Better Health program with a multichannel platform and a YouTube channel.
Market research firms Wolters Kluwer Health & Pharma Solutions and Decision Resources announced an agreement designed to make it easier for mutual customers to access managed markets data.
Roche, which is launching an HPV test, is sponsoring a blog by a UK healthcare reporter chronicling the process of getting a pap smear.
Merck is launching Build Smart, Breathe Easier, an asthma awareness campaign starring celebrity carpenter Carter Oosterhouse, who will build four homes with asthma-healthy features.
Amazing Race host Phil Keoghan will lead a Novartis-sponsored team of women pro cyclists on a 10-city bike tour to raise awareness of MS.
Pfizer is piloting a mobile education campaign promoting awareness of the value of childhood vaccinations through texting.
- Which drugmakers have the healthiest presence on social media?
- McCann Health forms new global consultancy
- Five things for pharma marketers to know: Monday, September 26, 2016
- Uber partners with startup to take patients to the doctor
- Five things for pharma marketers to know: Tuesday, September 27, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- When it comes to professional ads, print makes its comeback
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Drugmakers set their sights on the next potential blockbuster disease: NASH
- Five things for pharma marketers to know: Thursday, September 29, 2016
- BBDO picks up Neulasta; FCB gains Galderma and Sandoz work in the U.S.
- How to get more women in the C-suite, according to IPG, Unilever, and AOL
- Why Any Merger is the Last Resort of Lousy Marketers